We’re in. For our patients. For our people. For our communities. For delivering the greatest possible impact driven by our expertise, curiosity, and determination. We’re giving it everything we’ve got because every moment and every patient counts. Learn more at Insmed.com. #CountUsIn
Insmed Incorporated
Biotechnology Research
Bridgewater Township, New Jersey 41,769 followers
About us
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending three consecutive years as the No. 1 Science Top Employer. Join the Insmed team to accelerate your career and help make every moment and every patient count. Community guidelines: http://bit.ly/3DbEjVG
- Website
-
http://www.insmed.com/
External link for Insmed Incorporated
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Bridgewater Township, New Jersey
- Type
- Public Company
- Specialties
- Biotechnology, Orphan Disease State, Pharmaceuticals, Chronic Lung Infections, and Pulmonary
Locations
-
Primary
Get directions
700 US 206
Bridgewater Township, New Jersey 08807, US
Employees at Insmed Incorporated
Updates
-
Are you curious to see what a #DayInTheLife looks like at Insmed? Watch Christopher Caughy share more about his role as a Senior Case Manager on our Patient Services team. #CountUsIn
-
As we approach the end of the year, our teams around the world are gathering to celebrate and reflect on all that we’ve achieved together. Thank you for an incredible 2024. Here’s to 2025! 🎉 #CountUsIn
-
-
Congratulations to our CFO Sara Bonstein on being recently recognized as one of the Top 25 Biotech CFOs of 2024!
The Top 25 Biotech CFOs of 2024 This year’s awardees provide the financial expertise that enables their organizations to transform scientific discoveries into tangible therapies. They manage complex financial operations, raise capital to fund research and clinical trials, and ensure sustainable growth in an industry poised for significant expansion. Philip Boudreau (Abbott), Christiana Stamoulis (Incyte), Dominique Schutz (Foundation Medicine), Jeff Sherman (NeoGenomics), Sara Bonstein (Insmed), Maureen Marchek (BioAgilytix), Michael Landsittel (Blueprint Medicines), Jean-Marc Bellemin (Iovance Biotherapeutics), David Priestley, (Aegis Sciences), Kimi Iguchi (SAGE Therapeutics), Simon Harford (Amicus Therapeutics), Anthony Doyle (BioCryst Pharmaceuticals), Eva Ho (Crown Bioscience), Frank Stokes (Castle Biosciences), Ken Myszkowski (Arrowhead Pharmaceuticals), Steven Pieper (Xeris Biopharma), Rocco Venezia (Intercept Pharmaceuticals), Andrew Guggenhime (Vaxcyte), Johanna Mylet (Poseida Therapeutics), Kelly MacDonald (Dynavax Technologies), Tom Catinazzo (Relay Therapeutics), Dalen Meeter (Singular Genomics), Kevin Herde (Maravai Life Sciences), Sandeep "Steve" Laumas (Instil Bio). Sign up for our free email newsletter at https://lnkd.in/gr9RzWAW #finance #csuite #cfos #leadership #awards https://lnkd.in/gFadVDfy
-
We’re happy to share that our Chair and CEO Will Lewis was included on STAT News’ Best Biopharma CEOs list for 2024. We are grateful for Will’s leadership and the collective efforts of our outstanding team that help make notable achievements like this possible. #CountUsIn
-
-
At Insmed, we believe that every moment and every patient counts. That’s why, no matter the obstacles we face, we are determined to find a way or create one to make the greatest possible impact for patients living with serious diseases. If you’re looking for a new adventure in the new year, view our open roles and apply today: https://bit.ly/4dMr8wb #CountUsIn #Hiring
-
We’re looking forward to attending the 43rd Annual J.P. Morgan Healthcare Conference and Biotech Showcase in January. For those attending, we’d love to discuss how we can collaborate to transform the lives of patients. Email us at BD@insmed.com to schedule a meeting. #JPM2025 #CountUsIn
-
We’re pleased to share that we’ve been recognized across several categories in the large-cap ($10B-$50B market cap) #Biotech sector on 2024 Institutional Investor’s All-America Rankings annual list. Congratulations to our team members for their collective efforts in helping us achieve these recognitions. #CountUsIn
-
Today, we joined the BioNJ community to participate in a collective giving initiative, “BioNJ Gives Back.” We had a wonderful time building “BioBears,” superhero capes, and cards for pediatric patients at Children's Specialized Hospital. Giving back is central to who we are at Insmed, and we are grateful to BioNJ for this opportunity to support our local community. #CountUsIn
-
-
We’re looking forward to attending the Nasdaq 51st Investor Conference held in association with Morgan Stanley tomorrow, December 11, in London. Tune in to hear a fireside chat from Will Lewis, our Chair & CEO: https://bit.ly/3Bo5Hni #CountUsIn
-